BackPrometheus Biosciences Overview

Prometheus Biosciences Research & Development

Get informed when a big investor buys or sells

+ Follow

Quarterly R&D Expenses

$36.42M
30.39% YoY

As of Mar 31, 2023

Annual R&D Expenses (TTM)

$121.36M
46.92% YoY

Trailing 12 months ending Mar 31, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Prometheus Biosciences (RXDX) FAQ

Stockcircle tracks research & development for Prometheus Biosciences (RXDX), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Research & Development page is built for Prometheus Biosciences's historical R&D spending trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use R&D spending as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main RXDX overview so you can move from this figure to the surrounding analysis quickly.